PDCD1 and head and neck squamous cell carcinoma: CSC-derived EVs in head and neck squamous cell carcinoma (HNSCC) specifically interact with M2 macrophages and PD1+ T cells, crucial immune constituents enriched in CSC niche, contributing to immunosuppression landscape that impedes effective HNSCC therapy (30).